These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 34321567)

  • 1. High frequency and long persistency of ballooning hepatocyte were associated with glucose intolerance in patients with severe obesity.
    Kakisaka K; Sasaki A; Umemura A; Nikai H; Suzuki Y; Nishiya M; Sugai T; Nitta H; Takikawa Y
    Sci Rep; 2021 Jul; 11(1):15392. PubMed ID: 34321567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori infection might have a potential role in hepatocyte ballooning in nonalcoholic fatty liver disease.
    Sumida Y; Kanemasa K; Imai S; Mori K; Tanaka S; Shimokobe H; Kitamura Y; Fukumoto K; Kakutani A; Ohno T; Taketani H; Seko Y; Ishiba H; Hara T; Okajima A; Yamaguchi K; Moriguchi M; Mitsuyoshi H; Yasui K; Minami M; Itoh Y
    J Gastroenterol; 2015 Sep; 50(9):996-1004. PubMed ID: 25622927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bariatric Surgery Reduces Features of Nonalcoholic Steatohepatitis in Morbidly Obese Patients.
    Lassailly G; Caiazzo R; Buob D; Pigeyre M; Verkindt H; Labreuche J; Raverdy V; Leteurtre E; Dharancy S; Louvet A; Romon M; Duhamel A; Pattou F; Mathurin P
    Gastroenterology; 2015 Aug; 149(2):379-88; quiz e15-6. PubMed ID: 25917783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor-21 and omentin-1 hepatic mRNA expression and serum levels in morbidly obese women with non-alcoholic fatty liver disease.
    Waluga M; Kukla M; Zorniak M; Kajor M; Liszka L; Dyaczynski M; Kowalski G; Zadlo D; Waluga E; Olczyk P; Buldak RJ; Berdowska A; Hartleb M
    J Physiol Pharmacol; 2017 Jun; 68(3):363-374. PubMed ID: 28820393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum Fucosylated Haptoglobin as a Novel Diagnostic Biomarker for Predicting Hepatocyte Ballooning and Nonalcoholic Steatohepatitis.
    Kamada Y; Akita M; Takeda Y; Yamada S; Fujii H; Sawai Y; Doi Y; Asazawa H; Nakayama K; Mizutani K; Fujii H; Yakushijin T; Miyazaki M; Ezaki H; Hiramatsu N; Yoshida Y; Kiso S; Imai Y; Kawada N; Takehara T; Miyoshi E
    PLoS One; 2013; 8(6):e66328. PubMed ID: 23805214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma metabolic alterations in patients with severe obesity and non-alcoholic steatohepatitis.
    Cabré N; Luciano-Mateo F; Baiges-Gayà G; Fernández-Arroyo S; Rodríguez-Tomàs E; Hernández-Aguilera A; París M; Sabench F; Del Castillo D; López-Miranda J; Menéndez JA; Camps J; Joven J
    Aliment Pharmacol Ther; 2020 Feb; 51(3):374-387. PubMed ID: 31825539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.
    Yildiz BO; Yarali H; Oguz H; Bayraktar M
    J Clin Endocrinol Metab; 2003 May; 88(5):2031-6. PubMed ID: 12727950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automatic quantification of lobular inflammation and hepatocyte ballooning in nonalcoholic fatty liver disease liver biopsies.
    Vanderbeck S; Bockhorst J; Kleiner D; Komorowski R; Chalasani N; Gawrieh S
    Hum Pathol; 2015 May; 46(5):767-75. PubMed ID: 25776030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery.
    Seki Y; Kakizaki S; Horiguchi N; Hashizume H; Tojima H; Yamazaki Y; Sato K; Kusano M; Yamada M; Kasama K
    J Gastroenterol; 2016 Mar; 51(3):281-9. PubMed ID: 26314837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver disease: predictors of nonalcoholic steatohepatitis and gallbladder disease in morbid obesity.
    Liew PL; Lee WJ; Wang W; Lee YC; Chen WY; Fang CL; Huang MT
    Obes Surg; 2008 Jul; 18(7):847-53. PubMed ID: 18459024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity.
    Polotsky VY; Patil SP; Savransky V; Laffan A; Fonti S; Frame LA; Steele KE; Schweizter MA; Clark JM; Torbenson MS; Schwartz AR
    Am J Respir Crit Care Med; 2009 Feb; 179(3):228-34. PubMed ID: 18990675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Features of nonalcoholic steatohepatitis in severely obese children and adolescents undergoing sleeve gastrectomy.
    Alqahtani A; Elahmedi M; Alswat K; Arafah M; Fagih M; Lee J
    Surg Obes Relat Dis; 2017 Sep; 13(9):1599-1609. PubMed ID: 28600116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis.
    Pelusi S; Cespiati A; Rametta R; Pennisi G; Mannisto V; Rosso C; Baselli G; Dongiovanni P; Fracanzani AL; Badiali S; Maggioni M; Craxi A; Fargion S; Prati D; Nobili V; Bugianesi E; Romeo S; Pihlajamaki J; Petta S; Valenti L
    Clin Gastroenterol Hepatol; 2019 Oct; 17(11):2310-2319.e6. PubMed ID: 30708111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance.
    Gill RM; Allende D; Belt PH; Behling CA; Cummings OW; Guy CD; Carpenter D; Neuschwander-Tetri BA; Sanyal AJ; Tonascia J; Van Natta ML; Wilson LA; Yamada G; Yeh M; Kleiner DE;
    Hepatol Commun; 2023 Feb; 7(2):e0033. PubMed ID: 36724127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonalcoholic steatohepatitis associated with metabolic syndrome: relationship to insulin resistance and liver histology.
    Jung KY; Cho SY; Kim HJ; Kim SB; Song IH
    J Clin Gastroenterol; 2014; 48(10):883-8. PubMed ID: 24440936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery.
    Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C
    Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease.
    Kakisaka K; Suzuki Y; Fujiwara Y; Abe T; Yonezawa M; Kuroda H; Ishida K; Sugai T; Takikawa Y
    J Gastroenterol; 2018 Dec; 53(12):1285-1291. PubMed ID: 29680867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin Resistance Is Central to Long-Term Reversal of Histologic Nonalcoholic Steatohepatitis After Metabolic Surgery.
    Russo MF; Lembo E; Mari A; Angelini G; Verrastro O; Nanni G; Pompili M; Raffaelli M; Vecchio FM; Bornstein SR; Mingrone G
    J Clin Endocrinol Metab; 2021 Mar; 106(3):750-761. PubMed ID: 33248441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic steatosis in human immunodeficiency virus: a prospective study in patients without viral hepatitis, diabetes, or alcohol abuse.
    Sterling RK; Smith PG; Brunt EM
    J Clin Gastroenterol; 2013 Feb; 47(2):182-7. PubMed ID: 23059409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.